Israel's Smoking Problem: The Shift towards E-Cigarettes

Dec.12.2022
Israel's Smoking Problem: The Shift towards E-Cigarettes
Israel struggles to quit smoking as smoking rates remain unchanged at 20% despite the global shift towards e-cigarettes.

It seems that Israelis can't quit smoking. According to the Ministry of Health, the percentage of smokers in Israel has remained at 20% for many years, despite a steady increase in population. This means that the number of smokers in Israel is rising in proportion to the country's population.


It seems odd that, while many other developed countries around the world are turning to more innovative tobacco consumption methods, Israel still relies heavily on combustible cigarettes. Despite being known for its innovative solutions to a wide range of issues, why is Israel so far behind other developed countries in reducing smoking?


According to the global tobacco product manufacturer and leading cigarette supplier in Israel, Philip Morris International, the answer lies in taxation.


From a business standpoint, PMI aims to make profits, but the company has recognized ominous signs that electronic cigarettes seem to be the primary way of tobacco consumption in the future. PMI's objective is to stay ahead in this shift and has announced ambitions to have smoke-free products contribute to more than 50% of its total net revenue by 2025.


A few years ago, Philip Morris decided to undergo a dramatic and potentially historic change in regards to a global tobacco company. "Our vision for a smoke-free future could impact over 1 billion adult smokers worldwide," said Roi Amit, the general manager of PMI Israel. "PMI has made it clear that if you don't smoke, don't start. If you do smoke, quit. If you won't quit, then switch. Our goal is to develop advanced technology based on scientific research that minimizes the impact of traditional cigarettes (which rely on burning tobacco) and offers it as an alternative for adult smokers who aren't able to quit. Today, the company's resources are largely focused on realizing this vision.


PMI has made it clear that if you don't smoke, don't start. If you do smoke, quit. If you won't give it up, then change. The company's objective is to develop advanced alternatives based on scientific research in order to reduce the impact of traditional combustible cigarettes as much as possible and offer them as an alternative for adult smokers who cannot or will not quit. Currently, the majority of the company's resources are devoted to achieving this vision.


I'm sorry, but "王阿密" is not a phrase or sentence that can be translated to journalistic English. It appears to be a proper noun or name, which cannot be translated without additional context. Please provide more information or a complete sentence for translation.


All tobacco use is harmful, but smoke is the worst part.


However, electronic cigarettes with nicotine are also harmful to you. Based on experience, they are detrimental to your health.


While smoking is harmful, electronic cigarettes may have some marginal advantages as they can lower the risk of nicotine poisoning and exposure to harmful chemicals through inhalation for both the user and those around them, according to some studies. PMI hopes that smokers will switch to e-cigarettes if they are already smoking.


An independent study conducted by the UK government's public health agency, Public Health England, and the Royal College of Physicians advisory committee on tobacco shows that vaping is 95% healthier than smoking. However, other experts claim that e-cigarettes are just as dangerous as traditional smoking.


During an interview with the Jerusalem Post, Amit and several other PMI executives admitted that smoking is not healthy.


But when asked if PMI has considered completely stopping cigarette production - given how aware they are of the significant dangers of cigarettes - they stated that if they were to immediately cease cigarette production, one of the other leading cigarette brands in the market would quickly fill the gap.


They do not want this situation to occur and instead, they aim to use their market share to their advantage and gradually encourage people to move away from cigarettes, whether produced by them or anyone else, and turn to electronic cigarette products, preferably theirs. However, they first need to address a major obstacle hindering their progress: Israeli regulatory agencies.


Philip Morris International (PMI) is reportedly putting pressure on Israeli regulators to change their strict stance on taxing e-cigarettes. PMI argues that this is one of the main reasons why smoking rates in Israel have remained unchanged, despite the global trend towards decreasing tobacco use.


Situation of Electronic Cigarette Tax


In Japan, as of 2020, the overall tax on combustible cigarettes is 61 percent; the tax rate on heated tobacco products (HTP) is 52.14 percent. The 19 percent difference in tobacco and HTP taxes has played a significant role in prompting over 22 percent of adult male smokers to turn to less healthy options.


Similarly, in Denmark (where support for HTP stands at 154%), the UK (73%), Germany (123%), Italy (107%), and other countries, the number of smokers has declined in line with more favorable taxation for heated tobacco products.


As previously mentioned, the percentage of smokers in Israel has remained consistent (resulting in an increase in the number of smokers with population growth). Why is this the case?


Israel is the only country out of 39 OECD nations that imposes a tax rate on heated tobacco products (HTP) six percent higher than combustible cigarettes. This unique position among these countries provides a strong argument for PMI's case.


To succeed on the journey towards a smoke-free world, many things need to be done, and in other countries, these things are happening; but in Israel, they are not," Amit said. In this sense, he noted, "Israel has failed in areas where other countries have succeeded.


I don't blame the Ministry of Health. They have tried, but what I mean is that we should do more. To accelerate progress, public health agencies should partner with the tobacco industry to advance the concept of reducing tobacco harm in Israel. Combining higher safety standards, stricter enforcement, and prevention of sales to young people and adolescents - as is the strategy in other countries - regulators are called upon here to develop a local strategy for smoking products based on reducing harm caused by combustibles, and encourage alternatives to those who cannot quit smoking.


2FIRSTS will continue to track and report on this topic, with further updates available on the '2FIRSTSAPP.' Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
 PMI Opens Generative AI Center in Portugal to Support Global Operations
PMI Opens Generative AI Center in Portugal to Support Global Operations
According to information released by Portugal’s Trade & Investment Agency (AICEP) in July 2026, Philip Morris International (PMI) has established a global Generative Artificial Intelligence Factory (GenAI Factory) at its Portuguese subsidiary Tabaqueira. The center will support PMI’s global operations by developing and deploying AI solutions focused on industrial process optimization, data analytics, operational automation and AI application development. The initiative strengthens Portugal’s role in PMI’s global technology and innovation network.
Aug.27
Australia’s One Nation Proposes 75% Tobacco Tax Cut, Says Lower Prices Could Hit Illicit Market
Australia’s One Nation Proposes 75% Tobacco Tax Cut, Says Lower Prices Could Hit Illicit Market
Australia’s One Nation party has proposed cutting tobacco excise by 75%, arguing that lower legal cigarette prices could narrow the gap with illicit tobacco and reduce demand for black-market products. The proposal comes as Australia continues expanding enforcement against illicit tobacco supply chains through border controls, retail inspections and organised-crime investigations. Supporters argue high taxes have contributed to illicit-market growth, while opponents warn that lower tobacco prices could undermine public-health goals. The proposal is a party policy position and has not been adopted by the Australian government.
Aug.18
Germany's Four-Year Tobacco Tax Plan Heads to Parliament as BAT, JTI and PMI Push for Changes
Germany's Four-Year Tobacco Tax Plan Heads to Parliament as BAT, JTI and PMI Push for Changes
Germany's parliament is scheduled to hold a first reading of amendments to the Tobacco Tax Act on September 24. The government plans annual tax increases from 2027 through 2030 covering cigarettes, heated tobacco, vaping liquids and other categories. It expects the reform to generate €756 million in additional revenue in 2027, rising to €3.589 billion in additional annual revenue by 2030. Ahead of the parliamentary debate, the German Association of the Tobacco Industry and Novel Products, or BVTE, launched the "Tabaksteuer mit Augenmaß" campaign backed by BAT, JTI, Philip Morris, Reemtsma and wholesale and retail groups.
Sep.23
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canadian Health Minister Marjorie Michel says she is not considering loosening retail restrictions on nicotine pouches. Canada regulates pouches containing 4 mg or less of nicotine per unit as non-prescription nicotine replacement therapy and requires newer NRT formats such as pouches to be sold from behind pharmacy counters. Meanwhile, Unsmoke Canada, linked to Philip Morris International's Canadian business, is pushing to allow pouches in convenience stores and other general retail outlets. Health Canada also acknowledges continued unauthorized sales, while recent research shows rising pouch use among Canadian youth aged 16 to 19.
Sep.24
China Tobacco Zhejiang files patent for pressure-triggered, on-demand oral nicotine release
China Tobacco Zhejiang files patent for pressure-triggered, on-demand oral nicotine release
China Tobacco Zhejiang Industrial Co., Ltd. has filed a patent application for an oral nicotine delivery product designed to let users actively adjust nicotine release. The product embeds two types of nicotine reservoirs with different wall thicknesses and positions inside a deformable matrix. Pressure applied with the tongue or lips can rupture the reservoirs and accelerate nicotine release. In simulated oral tests, several patent examples showed sharply higher peak nicotine release rates as applied force increased from 0 N to 1 N and 3 N. The filing explores a shift from preset release profiles toward user-triggered nicotine delivery.
Sep.01